Combinations of isoprinosine and 3'-azido-3'-deoxythymidine in lymphocytes infected with human immunodeficiency virus type 1.

Since clinical trials are being planned with the immunomodulating drug isoprinosine combined with the antiviral drug 3'-azido-3'-deoxythymidine (AZT) in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex, it is important to determine the type of antiviral interaction pr...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Schinazi, R F, Cannon, D L, Arnold, B H, Martino-Saltzman, D
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1988
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC176018/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2469387/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.32.12.1784
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!